A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma

Name: A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
License: Public Domain

Ochsner Health System

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 125831
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.